CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Lilly Stock Rises as $870 Million Gate Deal Adds One Target

Positive
AI Analysis

Summary

Eli Lilly announced an $870 million acquisition of Gate Pharmaceuticals to add one therapeutic target to its pipeline, resulting in a stock price increase.

Importance:7/10
Sentiment:
0.60
acquisitionM&AEli LillyGate Pharmaceuticals
Related Companies

Read the original article

Published by yahoo_finance on October 6, 2026 7:46 PM

Read Original